An Overview of Guidelines for Menopause Hormone Therapy and a Review of Duavee Clinical Data
Please register to learn more about hormonal therapy in menopause. Dr. Gloria Richard-Davis will present key points from the NAMS (North American Menopause Society) hormone therapy position statement, an overview of the Women’s Health Initiative, and a review of the Duavee clinical data. The session will be moderated by Jennifer Virro, Medical Director, Women’s Health Medical Affairs at Pfizer.
We will be live streaming the same presentation across two sessions, both of which will have an opportunity for Q&A:
Monday, June 19th at 5:30-6:30 pm ET & Tuesday, June 20th at 8:30-9:30 pm ET
MODERATOR
Jennifer Virro, MD, MBA
Medical Director
Pfizer Women’s Health
SPEAKER
Gloria Richard-Davis, MD, MBA, NCMP, FACOG
University of Arkansas for Medical Sciences, Little Rock, AK
Dr. Richard-Davis is a NAMS Menopause Certified Practitioner and board certified OB/GYN and Reproductive Endocrinology and Infertility Specialist. She is also the executive director at the University of Arkansas for Medical Sciences Division for Diversity, Equity and Inclusion and a tenured professor in the Department of Obstetrics and Gynecology. She is a women’s health expert and specializes in menopause management.
